查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701828

2025 年至 2033 年即时诊断分子诊断市场报告（按产品与服务、技术、应用、最终用户和地区划分）

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2024 年，全球即时分子诊断市场规模达 40 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 87 亿美元，2025-2033 年期间的成长率 (CAGR) 为 8.78%。传染病发病率的上升和医疗设施的快速发展极大地推动了市场的成长。

即时诊断（POC）分子诊断是指由医师进行的诊断和检测传染病的测试。其中包括血液学、怀孕、生育、传染病、尿液分析测试套件以及心臟代谢和血糖监测设备。 POC分子诊断广泛用于识别传染性病原体、微小残留疾病和胃肠道疾病、监测血红蛋白和粪便潜血以及确定患者代谢药物或药物类别的能力。这些测试可以提供更快的结果，减少与滥用治疗相关的併发症，并改善感染控制措施。因此，POC分子诊断在医院、重症监护室（ICU）、研究机构、诊所、分散实验室和家庭护理机构中得到广泛的应用。

即时诊断分子诊断市场趋势：

全球范围内传染病的日益普及为市场带来了积极的前景。 POC 分子诊断测试是一种经济有效的解决方案，广泛用于管理传染病，例如流感、结核病、人类免疫缺陷病毒 (HIV) 感染、披衣菌和肝炎。此外，为了有效管理和控制 COVID-19 的传播，对 PCR 检测试剂盒的需求不断增长，这也是另一个促进成长的因素。此外，采用小型化、奈米技术和微流体技术开发低成本、用户友好且高灵敏度的分子诊断测试正在为市场成长提供动力。此外，政府为改善医疗保健基础设施和提高分子诊断能力而实施的各种措施正在对市场成长产生积极影响。其他因素，包括脱氧核糖核酸 (DNA) 定序的快速进步、对先进治疗和诊断测试的认识不断提高、老年人口的增加以及云端连接 POC 诊断技术的最新发展，预计将推动市场成长。

本报告回答的关键问题

  • 2024 年全球即时分子诊断市场规模？ 2025 年至 2033 年期间全球即时分子诊断市场的预期成长率为何？
  • 推动全球即时分子诊断市场发展的关键因素有哪些？
  • COVID-19 对全球即时分子诊断市场有何影响？
  • 根据产品和服务，全球即时分子诊断市场是如何分類的？
  • 根据技术，全球即时分子诊断市场如何划分？
  • 根据应用，全球即时分子诊断市场是如何分類的？
  • 全球即时分子诊断市场的主要区域有哪些？
  • 全球即时分子诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球即时分子诊断市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品与服务

  • 检测方法和试剂盒
  • 仪器和分析仪
  • 软体和服务

第七章：市场区隔：依技术

  • 聚合酶炼式反应（PCR）
  • 杂交
  • DNA定序
  • 微阵列
  • 等温核酸扩增技术（INAAT）
  • 其他的

第 8 章：市场区隔：按应用

  • 传染病
  • 肿瘤学
  • 血液学
  • 产前检查
  • 内分泌学
  • 其他的

第九章：市场区隔：依最终用户

  • 医生办公室
  • 医院及重症监护室
  • 研究机构
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Binx Health Inc.
    • Co-Diagnostics Inc.
    • F. Hoffmann-La Roche Ltd
    • Gene STAT Molecular Diagnostics LLC
    • Hemocue AB (Danaher Corporation)
    • Meridian Bioscience Inc.
    • Molbio Diagnostics Private Limited
    • Quidel Corporation
    • Siemens Healthcare GmbH (Siemens AG)
    • Thermo Fisher Scientific Inc.
    • Visby Medical Inc.
Product Code: SR112025A6271

The global point of care molecular diagnostics market size reached USD 4.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.7 Billion by 2033, exhibiting a growth rate (CAGR) of 8.78% during 2025-2033. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth.

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

Point of Care Molecular Diagnostics Market Trends:

The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. POC molecular diagnostic tests is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. Additionally, the rising demand for PCR test kits to effectively manage and control the spread of COVID-19 is acting as another growth-inducing factor. Furthermore, the adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product and Service:

  • Assays and Kits
  • Instruments and Analyzers
  • Software and Services

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • Hybridization
  • DNA sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Breakup by Application:

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Others

Breakup by End User:

  • Physicians' Offices
  • Hospitals and ICUs
  • Research Institutes
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global point of care molecular diagnostics market in 2024?
  • 2.What is the expected growth rate of the global point of care molecular diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global point of care molecular diagnostics market?
  • 4.What has been the impact of COVID-19 on the global point of care molecular diagnostics market?
  • 5.What is the breakup of the global point of care molecular diagnostics market based on the product and service?
  • 6.What is the breakup of the global point of care molecular diagnostics market based on the technology?
  • 7.What is the breakup of the global point of care molecular diagnostics market based on application?
  • 8.What are the key regions in the global point of care molecular diagnostics market?
  • 9.Who are the key players/companies in the global point of care molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point of Care Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Assays and kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments and Analyzers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prenatal Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Endocrinology
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Physicians' Offices
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and ICUs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Binx Health Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Co-Diagnostics Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 F. Hoffmann-La Roche Ltd
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Gene STAT Molecular Diagnostics LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Hemocue AB (Danaher Corporation)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Meridian Bioscience Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Molbio Diagnostics Private Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Quidel Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Siemens Healthcare GmbH (Siemens AG)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Visby Medical Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2024
  • Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
  • Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million USD), 2025-2033
  • Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players